Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer [NA]
A prospective study using hybrid PET/MRI to evaluate men with suspected recurrence of prostate cancer after treatment.
-
EMA safety_alert · 2018-07-27EMA restricts use of prostate cancer medicine Xofigo
The EMA restricts the use of Xofigo (radium-223 dichloride) for prostate cancer due to safety concerns and updated recommendations.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Clinical trial update reports safety, pharmacokinetics and proof-of-concept results for ARN-509 (apalutamide) in castration-resistant prosta…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study
The PASCUAL study evaluating a prostate cancer assay sponsored by MDx Health has been terminated.
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma
This clinical trial update investigates whether SPECT-CT quantitative indices can prognostically predict response in bone-metastatic prostat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy [EARLY_Phase 1]
This clinical trial update notes the completion of an EARLY_PHASE1 study evaluating vismodegib in men with metastatic castration-resistant p…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
This clinical trial update notes the termination of the study evaluating the NantHealth GPS Cancer Test in patients with advanced cancers. T…
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging [NA]
A clinical trial evaluating imaging of prostate cancer using two-dimensional MR spectroscopy and diffusion tensor imaging has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating IMC-A12 (Cixutumumab) in metastatic prostate cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive [Phase 2]
Phase 2 trial comparing ipilimumab 3 mg/kg vs 10 mg/kg in chemotherapy-naive metastatic castration-resistant prostate cancer; results posted…
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial
A multicenter prospective trial evaluating the correlation between the iXip device/assay and final pathology specimens from radical prostate…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen. [Phase 2]
A Phase 2 clinical trial evaluating Vitamin D3 (cholecalciferol) supplementation in men with early-stage prostate cancer choosing active sur…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating two doses of MPX capsules on rising PSA after initial therapy in prostate cancer patients; study complet…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer [Phase 2]
Phase 2 trial update of Provenge (sipuleucel-T) with or without pTVG-HP DNA booster vaccine in prostate cancer completed with results posted…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]
Phase 2 clinical trial evaluating gefitinib and etoposide in advanced prostate cancer resistant to hormone therapy; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer [Phase 1]
A Phase 1 study evaluated allogeneic human bone marrow-derived mesenchymal stem cells in localized prostate cancer. The trial has been termi…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer [Phase 1, Phase 2]
Phase Ib/IIa trial evaluating cabazitaxel plus bavituximab in castration-resistant prostate cancer was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery [NA]
This update notes that the Dana-Farber Cancer Institute's trial evaluating polyunsaturated fatty acids in men with prostate cancer undergoin…
-
CLINICAL_TRIALS other · 2018-07-13Clinical Trial Update: Intensity Modulated Versus Interstitial - Radiation Therapy [NA]
This document provides an update on a clinical trial comparing intensity-modulated radiation therapy with interstitial radiation therapy for…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer [Phase 3]
Phase 3 clinical trial update for enzalutamide in nonmetastatic castration-resistant prostate cancer; the study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone [Phase 2]
Phase 2 trial comparing standard dose, high dose, and extended standard dose of Radium-223 dichloride in metastatic castration-resistant pro…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Intraprostatic MAXimal Simultaneous Boost [NA]
This clinical trial update reports that the intraprostatic maximal simultaneous boost trial in prostate cancer has been terminated.
-
CLINICAL_TRIALS research · 2018-07-10Clinical Trial Update: Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
This clinical trial update reports development and initial clinical assessment of a prostate cancer risk model based on an updated circulati…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency [Phase 3]
An ongoing Phase 3 clinical trial is evaluating Everolimus in castration-resistant prostate cancer patients who have deficiencies in the PI3…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer [Phase 1]
Phase 1 trial evaluating ferumoxytol-enhanced MRI for detecting lymph node involvement in prostate cancer has completed.